Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue December 2014
 •  Antitrust Regulator in France Fines Major Companies  •  Paradigm Science‚Äôs Cervino Wins Award  •  Aquaphor Taps Brooke Burke  •  Shea Radiance Gets A Makeover  •  A Sustainable P&G
Print

Valeant To Buy Bausch & Lomb



Published May 27, 2013
Related Searches: skin continue care companies
Post a comment
Valeant Pharmaceuticals International will pay $8.7 billion to acquire Bausch & Lomb, the eye care company. Under the terms of the deal, Valeant will pay $4.5 billion to the investor group that owns Bausch & Lomb, led by private equity firm Warburg Pincus. It will also spend about $4.2 billion to repay Bausch & Lomb’s debt.

 

The agreement continues the flurry of deal-making in the health care industry, as companies seek to buy the growth they are hard-pressed to generate on their own. Announced merger volume in the sector this year is up 14% from the period a year earlier, even as takeovers have fallen 8%.


This acquisition follows Valeant's April purchase for Obagi skin care for $348 million.

 



blog comments powered by Disqus